Biotech

All Articles

ReNeuron leaving behind purpose exchange after missing out on fundraising objective

.ReNeuron has joined the long list of biotechs to leave behind London's goal securities market. The ...

MBX files for IPO to take opposition to Ascendis in to stage 3

.MBX Biosciences has actually included in the latest outbreak of IPO filings. The biotech, which fil...

FDA increases probe right into Lykos' MDMA tests: WSJ

.For Lykos Therapies and also the firm's potential MDMA-assisted therapy for post-traumatic stress d...

Gene publisher Tome giving up 131 employees

.Merely days after gene editor Tome Biosciences introduced hidden operational cuts, a clearer image ...

Repare lays off 25% of personnel as biotech halts preclinical R&ampD

.Repare Therapeutics is giving up a fourth of its own workforce as the oncology biotech scales back ...

J &amp J apply for FDA approval of $6.5 B autoimmune medicine

.Johnson &amp Johnson has taken yet another step toward understanding a gain on its own $6.5 billion...

Gain's stage 1 win paves means to show Parkinson's medication's worth

.Increase Therapies has actually set its own sights on proving the effectiveness of its Parkinson's ...

Actinogen files brand-new stage 2 information to restore clinical depression drug

.Actinogen Medical's hopes-- as well as inventory rate-- have recoiled a little from earlier this mo...

Pfizer and Main add Quotient to multibillion-dollar equation

.Flagship Pioneering and also Pfizer have actually incorporated Ratio into their 10-program collabor...

Bayer pens $547M contract to press borders of noncoding RNA

.Bayer executives were actually interested to stress to Ferocious this summer months that the German...